Folliculotropic mycosis fungoides with eosinophilia and CD30+ large-cell transformation: A case with a fatal outcome presenting with multifocal lesions and leonine facies: Clinical dermatology • Concise report

Clinical and Experimental Dermatology

Volumn 35, Issue 4, 2010, Pages

  Ishibashi, M ^a   Ohshima, K ^b   Chen, K R ^a  

^a SAISEIKAI CENTRAL HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR3; GRANZYME B; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; PREDNISOLONE; PROTEIN BCL 2;

ADULT; ALOPECIA; ARTICLE; AUTOPSY; BACTERIAL SKIN DISEASE; BLAST TRANSFORMATION; CASE REPORT; CYTOKINE PRODUCTION; EOSINOPHILIA; ERYTHRODERMA; FACE EDEMA; FACE MALFORMATION; FATALITY; FOLLICULOTROPIC MYCOSIS FUNGOIDES; HUMAN; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LENTIGO; LEONINE FACE; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MYCOSIS FUNGOIDES; POIKILODERMA; PRIORITY JOURNAL; SKIN BIOPSY; SPLENOMEGALY; TH2 CELL; TOTAL SKIN ELECTRON THERAPY;

ADULT; EOSINOPHILIA; FACIAL NEOPLASMS; FACIES; FATAL OUTCOME; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MYCOSIS FUNGOIDES; SKIN NEOPLASMS;

EID: 77951246279     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03752.x     Document Type: Article

References (10)

1. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 3785. (Pubitemid 40656118)
2. van Doorn R, Scheffer E, Willemze R. Follicular mycosis fungoides: a distinct disease entity with or without associated follicular mucinosis. Arch Dermatol 2001 138 : 191 198.
3. Gerami P, Guitart J. The spectrum of histopathologic and immunohistochemical findings in folliculotropic mycosis fungoides. Am J Surg Pathol 2007 31 : 1430 1438. (Pubitemid 47329681)
4. Gerami P, Rosen S, Kuzel T et al. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma. Arch Dermatol 2008 144 : 738 746. (Pubitemid 351846874)
5. Tancrède-Bohin E, Ionescu MA, de La Salmonière P et al. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol 2004 140 : 1057 1061. (Pubitemid 39223112)
6. Ionescu MA, Rivet J, Daneshpouy M et al. In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia. J Am Acad Dermatol 2005 52 : 32 9. (Pubitemid 40038933)
7. Diamandidou E, Colome-Grimmer M, Fayad L et al. Transformation of mycosis fungoides/Sézary syndrome: clinical characteristics and prognosis. Blood 1998 92 : 1150 1159. (Pubitemid 28369027)
8. Chong BF, Wilson AJ, Gibson HM et al. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides. Clin Cancer Res 2008 14 : 646 653.
9. Yagi H, Seo N, Ohshima A et al. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol 2006 30 : 1111 1119. (Pubitemid 44299344)
10. Suchin KB, Cassin M, Gottleib SL et al. Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12. J Am Acad Dermatol 2001 44 : 28 32. (Pubitemid 32110559)